F-Tag Library On-Demand Series-[UPDATED!] F756 Drug Regimen Review

Video Transcription

Video Summary

This presentation on F756, Drug Regimen Review, outlines regulatory requirements for monthly medication regimen reviews conducted by a licensed pharmacist for every resident in a facility. The pharmacist must review the resident's medical chart, identify any irregularities such as unnecessary medications, and report these to the attending physician, medical director, and director of nursing (DON). The physician must document review and actions taken or provide clinical rationale if no changes are made. Facilities are required to have policies specifying timeframes and procedures for addressing identified irregularities, including urgent interventions.<br /><br />The review aims to maintain residents' physical, mental, and psychosocial well-being by preventing adverse medication-related events. It must consider resident preferences, clinical indications, drug interactions, and monitoring adequacy. All residents, short- or long-stay, must be reviewed monthly, with more frequent reviews if conditions warrant. Electronic health records may assist but cannot replace comprehensive review involving direct communication and observation.<br /><br />Noncompliance examples include failure to conduct reviews, incomplete documentation, or lack of physician response to pharmacist findings. Facilities must analyze root causes of deficiencies, implement corrective actions for affected and at-risk residents, revise policies, educate staff, and monitor adherence to prevent recurrence. Surveyors use specific pathways and severity guidelines to evaluate compliance and psychosocial impact. Resources and training materials are available to support facilities in meeting these standards.

Keywords

F756

Drug Regimen Review

monthly medication review

licensed pharmacist

medication irregularities

physician documentation

facility compliance